Log in

Relevant bibliographies by topics / Chemotherapy / Journal articles

To see the other types of publications on this topic, follow the link: Chemotherapy.

Journal articles on the topic 'Chemotherapy'

Author: Grafiati

Published: 4 June 2021

Last updated: 25 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Chemotherapy.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Armini, Ni ketut alit, Masfin Muhayanah, and Aria Nastiti. "DIARRHEA INCIDENT IN CERVICAL CANCER PATIENTS POST CHEMOTHERAPY TREATMENT." Jurnal NERS 11, no. 1 (2016): 106. http://dx.doi.org/10.20473/jn.v11i12016.106-111.

Full text

Abstract:

Backgrounds : Cervical cancer is second most diseases suffered by women. Chemotherapy is primary treatment for cervical cancer. Chemotherpy has some side effect, and one of them is diarrhea. Diarrhea make cervical cancer suffered more. The purpose of this research was to analyze the correlation of factor’s that cause diarrhea on cervical cancer.Methods : This research uses descriptive analitic method with retrospective design. The population in this research is all patients who had post first chemotherapy. Sample in this study were 21 respondents, with purposive sampling. Variable independent

APA, Harvard, Vancouver, ISO, and other styles

2

Armini, Ni ketut alit, Masfin Muhayanah, and Aria Nastiti. "The Incident of Diarrhea among Cervical Cancer Patients Post Chemoterapy Treatment." Jurnal Ners 11, no. 1 (2016): 106–11. http://dx.doi.org/10.20473/jn.v11i1.1357.

Full text

Abstract:

Backgrounds : Cervical cancer is second most diseases suffered by women. Chemotherapy is primary treatment for cervical cancer. Chemotherpy has some side effect, and one of them is diarrhea. Diarrhea make cervical cancer suffered more. The purpose of this research was to analyze the correlation of factor’s that cause diarrhea on cervical cancer.Methods : This research uses descriptive analitic method with retrospective design. The population in this research is all patients who had post first chemotherapy. Sample in this study were 21 respondents, with purposive sampling. Variable independent

APA, Harvard, Vancouver, ISO, and other styles

3

Akl, Maher Monir. "Glucosodiene: Opening a New Branch of Chemotherapic Sciences Called Toxinutromedicanical-Chemotherapy." Cell & Cellular Life Sciences Journal 8, no. 2 (2023): 1–2. http://dx.doi.org/10.23880/cclsj-16000185.

Full text

Abstract:

Chemotherapy is a widely employed treatment modality in the fight against cancer aiming to eliminate both normal and cancerous cells. However, its non-discriminatory nature leads to severe side effects

APA, Harvard, Vancouver, ISO, and other styles

4

Rahiman K, Jassim. "Chemotherapy-Induced Neurotoxicity." International Journal of Science and Research (IJSR) 13, no. 8 (2024): 1250–54. http://dx.doi.org/10.21275/sr24820170848.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Dougherty, Lisa. "Practical Chemotherapy Practical Chemotherapy." Nursing Standard 17, no. 41 (2003): 29. http://dx.doi.org/10.7748/ns2003.06.17.41.29.b333.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Fitrianingsih, Nining. "HUBUNGAN TINGKAT PENGETAHUAN PERAWAT TENTANG KEMOTERAPI DENGAN TINDAKAN PEMBERIAN KEMOTERAPI PADA PASIEN KANKER PARU." Jurnal Persatuan Perawat Nasional Indonesia (JPPNI) 1, no. 3 (2017): 207. http://dx.doi.org/10.32419/jppni.v1i3.31.

Full text

Abstract:

ABSTRAKLatar Belakang: Kemoterapi merupakan salah satu cara pengobatan kanker dengan memberikanobat atau zat yang berkhasiat membunuh sel kanker. Dalam tindakan medis, perawat harusmemiliki pengetahuan tentang prosedur pemberian obat kemoterapi karena pemberian kemoterapiyang dilakukan oleh perawat rentan terkena pada kulit atau mata pada saat melakukan tindakan.Tujuan Penelitian: mengetahui hubungan tingkat pengetahuan perawat tentang kemoterapidengan tindakan pemberian kemoterapi pada pasien kanker paru. Metode: Desain penelitianyang digunakan ialah analisis korelasional dengan pendekatan cr

APA, Harvard, Vancouver, ISO, and other styles

7

Winata, I. Gde Sastra GdeSastra. "Neoadjuvant Chemotherapy In Stadium Ib3, Iia2 And Iib Cervical Cancer." Andalas Obstetrics And Gynecology Journal 7, no. 1 (2023): 214–24. http://dx.doi.org/10.25077/aoj.7.1.214-224.2023.

Full text

Abstract:

Aim:Â This studyÂ aimed to describe Paclitaxel-Carboplatin chemotherapy as neoadjuvant chemotherapy in stage IB3, IIA2 and IIB cervical cancer.Â Materials and Methods:Â The review was conducted by collecting journals from previous studies discussing neoadjuvant chemotherapy in cervical cancer stages IB3, IIA2, and IIB and in this case specifically discussing Paclitaxel-Carboplatin chemotherapy.Â Results:Â Neoadjuvan chemotherapy refers to systemic therapy intended to reduce the size of the tumor before the definitive operation. Several studies have shown that neoadjuvant chemotherapy has great

APA, Harvard, Vancouver, ISO, and other styles

8

Chung, Fu-Tsai, Ming-Yun Ho, Yueh-Fu Fang, et al. "The Impact of Sequence of Chemotherapy and EGFR-TKI Treatment on DifferentEGFRMutation Lung Adenocarcinoma." BioMed Research International 2015 (2015): 1–8. http://dx.doi.org/10.1155/2015/948267.

Full text

Abstract:

Objectives. Chemotherapy as first-/second-line treatment in different epidermal growth factor receptor (EGFR) mutation lung adenocarcinoma remains controversial.Methods. Consecutive patients were collected between 2009 and 2012. Patients were divided into two groups (1st-line chemotherapy:n= 56 and 2nd-line chemotherapy:n= 55). Their outcomes profiles were analyzed.Results. The overall survival (OS) of all patients (390 versus 662 days,p< 0.0001), as well as both progression-free survival (PFS, 151 versus 252 days,p= 0.0001) and OS (308 versus 704 days,p= 0.0001) of patients withL858Rmutati

APA, Harvard, Vancouver, ISO, and other styles

9

Friedrich, Michael, Alexander Khudyakov, Arne Terjung, Wolfgang Zinn, and Ulrich Füllers. "Influence of hyperthermic intraperitoneal chemotherapy (HIPEC) on the onset of adjuvant chemotherapy in ovarian cancer." Voprosy ginekologii, akušerstva i perinatologii 21, no. 2 (2022): 14–17. http://dx.doi.org/10.20953/1726-1678-2022-2-14-17.

Full text

Abstract:

Objective. To determine the benefits of intraoperative hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of advanced ovarian cancer. Patients and methods. The study included 87 patients, while 74 patients had epithelial ovarian cancer and 13 patients showed other neoplasms. At the end of the operation, a 1-hour perfusion of the abdominal cavity was performed with cisplatin 50 mg/m2 at a temperature of 41°C. The patient data was retrospectively analyzed considering the time interval of postoperative chemotherapy based on the guideline. Results. Sixty patients manifested macrosc

APA, Harvard, Vancouver, ISO, and other styles

10

S., Karthik, Seenivasan P., and Rajanandh M.G. "Pattern of Chemotherapy Induced Alopecia." Indian Journal of Cancer Education and Research 4, no. 2 (2016): 45–47. http://dx.doi.org/10.21088/ijcer.2321.9815.4216.1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Lucas, Amalorpavamari, Abijah Princy B, Latha Gracelin P, Merlin Nancy Deepa W, and Shiny Angel S. "Symptom Distress and Chemotherapy Induced Nausea, Vomiting and Retching (CINVR) among Cancer Patients undergoing Chemotherapy." International Journal of Science and Research (IJSR) 10, no. 7 (2021): 503–6. https://doi.org/10.21275/sr21709082808.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Loredo, Felipe Pereira de, Sabrina Ramos Bianco, Sildomar Queiroz e. Silva, and Daniella Paula Dias Coelho. "Comparison between tomosynthesis and breast magnetic resonance imaging to assess tumor response after neoadjuvant chemotherapy: a case report." Núcleo do Conhecimento 12, no. 07 (2021): 56–65. https://doi.org/10.32749/nucleodoconhecimento.com.br/health/neoadjuvant-chemotherapy.

Full text

Abstract:

Increasingly, the surgical treatment of breast cancer has been preserving as much tissue as possible, avoiding mutilating surgeries such as mastectomies. Therefore, it is necessary to analyze the morphological characteristics, location and size of the tumor, and neoadjuvant chemotherapy is often used to reduce the tumor mass and thus enable conservative surgery. The evaluation of tumor response to neoadjuvant chemotherapy has magnetic resonance imaging as the gold standard, which, however, is not always accessible, has a high cost and is contraindicated for claustrophobic and obese patients. T

APA, Harvard, Vancouver, ISO, and other styles

13

David, Ortiz Ciruela, López Andreu Aitana, Madrazo González Zoilo, and Rebassa Torrens María. "Chemotherapy-Associated Pneumatosis Intestinalis." International Journal of Clinical Science and Medical Research 04, no. 10 (2024): 374–75. https://doi.org/10.5281/zenodo.13985228.

Full text

Abstract:

Abstract A 65-year-old woman underwent surgery for squamous cell carcinoma of the left tonsil (pT2pN1M0) requiring adjuvant radiotherapy and chemotherapy (cisplatin). After the second cycle of chemotherapy, the patient arrived at the Emergency Department complaining of dysphagia, dyspnoea, and cervical subcutaneous emphysema, with unremarkable abdominal examination and laboratory tests. Contrast- <strong><em> </em></strong>enhanced cervico-thoraco-abdominal CT scan with oral and intravenous contrast (fig. 1 and 2) revealed cervical and thoracic subcutaneous emphysema, pneumomediastinum, p

APA, Harvard, Vancouver, ISO, and other styles

14

Takahashi, M. "Chemotherapy." Nihon Kikan Shokudoka Gakkai Kaiho 72, no. 2 (2021): 93–96. http://dx.doi.org/10.2468/jbes.72.93.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Deasy, Michael J. "Chemotherapy." Dental Clinics of North America 34, no. 1 (1990): 1–11. http://dx.doi.org/10.1016/s0011-8532(22)01158-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Engelking, Constance. "Chemotherapy." American Journal of Nursing 87, no. 11 (1987): 1438. http://dx.doi.org/10.2307/3425898.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Pope, Robert. "Chemotherapy." Academic Medicine 92, no. 1 (2017): 76. http://dx.doi.org/10.1097/acm.0000000000001492.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Smith, Dorothy B. "Chemotherapy." Journal of Wound, Ostomy and Continence Nursing 15, no. 3 (1988): 138–39. http://dx.doi.org/10.1097/00152192-198805000-00024.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Gordon, Philip H. "Chemotherapy." Diseases of the Colon & Rectum 61, no. 3 (2018): 275–78. http://dx.doi.org/10.1097/dcr.0000000000001040.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Grajny, Agatha E., Donna Christie, Anna M. Tichy, and Marie L. Talashek. "Chemotherapy." Home Healthcare Nurse: The Journal for the Home Care and Hospice Professional 11, no. 5 (1993): 51–58. http://dx.doi.org/10.1097/00004045-199309000-00009.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

OMURA, G. A. "Chemotherapy." JNCI Journal of the National Cancer Institute 84, no. 19 (1992): 1532–33. http://dx.doi.org/10.1093/jnci/84.19.1532-a.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Kozlowski, James M. "Chemotherapy." Journal of Urology 147, no. 3 Part 2 (1992): 938–41. http://dx.doi.org/10.1016/s0022-5347(17)37428-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Terry, Anna R., and Scott R. Plotkin. "Chemotherapy:." Otolaryngologic Clinics of North America 45, no. 2 (2012): 471–86. http://dx.doi.org/10.1016/j.otc.2011.12.013.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Pinedo, Herbert M., and Giuseppe Giaccone. "Chemotherapy." Lancet 349 (May 1997): S7—S9. http://dx.doi.org/10.1016/s0140-6736(97)90012-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Canter, Robert J. "Chemotherapy." Surgical Oncology Clinics of North America 25, no. 4 (2016): 861–72. http://dx.doi.org/10.1016/j.soc.2016.05.013.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Needleman, Richard. "Chemotherapy." AAOHN Journal 35, no. 4 (1987): 179–82. http://dx.doi.org/10.1177/216507998703500408.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Lewis, Brian J. "Chemotherapy." International Journal of Radiation Oncology*Biology*Physics 17 (January 1989): 106. http://dx.doi.org/10.1016/0360-3016(89)90618-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Arnold, R., A. Rinke, Ch Schmidt, and L. Hofbauer. "Chemotherapy." Best Practice & Research Clinical Gastroenterology 19, no. 4 (2005): 649–56. http://dx.doi.org/10.1016/j.bpg.2005.04.004.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Sugerman, Deborah Tolmach. "Chemotherapy." JAMA 310, no. 2 (2013): 218. http://dx.doi.org/10.1001/jama.2013.5525.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Grunberger, Aimée. "Chemotherapy." JAMA: The Journal of the American Medical Association 273, no. 7 (1995): 534b. http://dx.doi.org/10.1001/jama.1995.03520310030024.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Rousseau, Paul. "Chemotherapy." JAMA 298, no. 6 (2007): 604. http://dx.doi.org/10.1001/jama.298.6.604.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Li, Yiu-Tai, Szu-Ting Yang, and Peng-Hui Wang. "Chemotherapy adjuvant and chemotherapy-induced neutropenia." Taiwanese Journal of Obstetrics and Gynecology 61, no. 4 (2022): 573–74. http://dx.doi.org/10.1016/j.tjog.2022.05.001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Ernani, Vinicius. "Nasopharyngeal Carcinoma: Chemotherapy or No Chemotherapy?" Journal of Oncology Practice 14, no. 10 (2018): 607–8. http://dx.doi.org/10.1200/jop.18.00532.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Henderson, Craig. "Chemotherapy treatments: chemotherapy for breast cancer." International Journal of Radiation Oncology*Biology*Physics 24 (January 1992): 93–94. http://dx.doi.org/10.1016/0360-3016(92)90075-s.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Middleton, Justin, Daniel Stover, and Tsonwin Hai. "Chemotherapy-Exacerbated Breast Cancer Metastasis: A Paradox Explainable by Dysregulated Adaptive-Response." International Journal of Molecular Sciences 19, no. 11 (2018): 3333. http://dx.doi.org/10.3390/ijms19113333.

Full text

Abstract:

An emerging picture in cancer biology is that, paradoxically, chemotherapy can actively induce changes that favor cancer progression. These pro-cancer changes can be either inside (intrinsic) or outside (extrinsic) the cancer cells. In this review, we will discuss the extrinsic pro-cancer effect of chemotherapy; that is, the effect of chemotherapy on the non-cancer host cells to promote cancer progression. We will focus on metastasis, and will first discuss recent data from mouse models of breast cancer. Despite reducing the size of primary tumors, chemotherapy changes the tumor microenvironme

APA, Harvard, Vancouver, ISO, and other styles

36

Derks, Jules L., Robert Jan van Suylen, Erik Thunnissen, et al. "Chemotherapy for pulmonary large cell neuroendocrine carcinomas: does the regimen matter?" European Respiratory Journal 49, no. 6 (2017): 1601838. http://dx.doi.org/10.1183/13993003.01838-2016.

Full text

Abstract:

Pulmonary large cell neuroendocrine carcinoma (LCNEC) is rare. Chemotherapy for metastatic LCNEC ranges from small cell lung carcinoma (SCLC) regimens to nonsmall cell lung carcinoma (NSCLC) chemotherapy regimens. We analysed outcomes of chemotherapy treatments for LCNEC.The Netherlands Cancer Registry and Netherlands Pathology Registry (PALGA) were searched for patients with stage IV chemotherapy-treated LCNEC (2003–2012). For 207 patients, histology slides were available for pathology panel review. First-line platinum-based combined chemotherapy was clustered as “NSCLC-t”, comprising gemcita

APA, Harvard, Vancouver, ISO, and other styles

37

(R.T), Dr C. S. K. Prakash, M. D. "Nasopharyngeal Carcinoma- Role of External Beam Radiotherapy (EBRT) and Chemotherapy Vs EBRT, Chemotherapy and Intraluminal Brachytherapy." Journal of Medical Science And clinical Research 04, no. 10 (2016): 13348–61. http://dx.doi.org/10.18535/jmscr/v4i10.92.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Moha, Rico. "Chemotherapy medication of Vincristine and Vinblastine." Cancer Research and Cellular Therapeutics 1, no. 1 (2017): 01–02. http://dx.doi.org/10.31579/2640-1053/007.

Full text

Abstract:

Cancers treated with Vincristine and vinblastine include: acute leukemia, Hodgkin's and non- Hodgkin's lymphoma, neuroblastoma, rhabdomyosarcoma, Ewing's sarcoma, Wilms' tumor, multiple myeloma, chronic leukemias, thyroid cancer, brain tumors, non-small cell lung cancer, bladder cancer, melanoma, and testicular cancer andIt is also used to treat some blood disorders. It is given by injection into a vein. Vincristine and vinblastine exhibit differential activity against tumors and normal tissues. In this work, a number of cultured cell lines were assayed for their sensitivity to the antiprolife

APA, Harvard, Vancouver, ISO, and other styles

39

Yamashita, Tatsuya. "Chemotherapy for advanced hepatocellular carcinoma: systemic chemotherapy or hepatic arterial infusion chemotherapy?" Journal of Gastroenterology 39, no. 4 (2004): 404–6. http://dx.doi.org/10.1007/s00535-004-1330-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Ardhiansyah, Azril Okta, IB Tjakra Wibawa Manuaba, and I. Ketut Widiana. "Post-Chemotherapy Monocytopenia as a Predictor of Chemotherapy – Induced Neutropenia in Breast Cancer Patients." Bali Medical Journal 11, no. 3 (2022): 1325–30. http://dx.doi.org/10.15562/bmj.v11i3.2844.

Full text

Abstract:

Background: Chemotherapy-induced neutropenia (CIN) is chemotherapy's most frequent myelosuppression effect. Previous studies have examined static prognostic factors to assess dynamic neutrophil changes in each cycle. This study focuses on post-chemotherapy monocytopenia as a more dynamic predictor of CIN. This research aimed to know whether post-chemotherapy monocytopenia can be used as a predictor of CIN in breast cancer patients undergoing the chemotherapy cycle. Methods: This research used a prospective and a retrospective longitudinal cohort of breast cancer patients undergo a CAF regimen

APA, Harvard, Vancouver, ISO, and other styles

41

Cai, Runkai, Jianwei Zhang, Yue Cai, et al. "Adjuvant chemotherapy in ypStage III locally advanced rectal cancer after neoadjuvant treatment with an oxaliplatin-based regimen." Journal of Clinical Oncology 41, no. 16_suppl (2023): e15628-e15628. http://dx.doi.org/10.1200/jco.2023.41.16_suppl.e15628.

Full text

Abstract:

e15628 Background: Fluorouracil -based neoadjuvant chemoradiotherapy(CRT) followed by total mesorectal excision and adjuvant chemotherapy is the standard treatment for locally advanced rectal cancer (LARC). Adjvuant FOLFOX improved survival benefit compared with fluorouracil in patients with ypStage II andIII after CRT. However, induction or consolidation chemotherapy with FOLFOX before surgery had been the new standard for LARC. Whether adjuvant chemotherapy with FOLFOX still improves survival outcomes in ypStage III patients previously exposed to oxaliplatin-based treatment was unknwon. Meth

APA, Harvard, Vancouver, ISO, and other styles

42

Raval, Vishal, R. Christopher Bowen, Hansell Soto, and Arun Singh. "Chemotherapy for Retinoblastoma: Impact of Intravitreal Chemotherapy." Asia-Pacific Journal of Ophthalmology 10, no. 2 (2020): 200–202. http://dx.doi.org/10.1097/apo.0000000000000322.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Spellman, E., and A. Page. "Chemotherapy information cards for staff administering chemotherapy." European Journal of Cancer 37 (April 2001): S412. http://dx.doi.org/10.1016/s0959-8049(01)81969-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Rosell, R., M. Taron, A. Vergnenegre, et al. "38IN CHEMOTHERAPY SELECTION ACCORDING TO CHEMOTHERAPY BIOMARKERS." Lung Cancer 71 (February 2011): S22—S23. http://dx.doi.org/10.1016/s0169-5002(11)70175-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Schorge, John O. "Chemotherapy-free, but not quite free chemotherapy." Lancet Oncology 20, no. 10 (2019): 1335–37. http://dx.doi.org/10.1016/s1470-2045(19)30492-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Ando, Yuichi, Akiko Ota, and Rie Tsuboi. "Introduction of chemotherapy (Molecular targeting agent・Chemotherapy)." Toukeibu Gan 42, no. 3 (2016): 309–15. http://dx.doi.org/10.5981/jjhnc.42.309.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Sun, Danyang, Junxun Ma, Jinliang Wang, et al. "Anti-PD-1 therapy combined with chemotherapy in patients with advanced pancreas cancer in a real-world clinical setting." Journal of Clinical Oncology 37, no. 15_suppl (2019): e14103-e14103. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.e14103.

Full text

Abstract:

e14103 Background: Pancreatic cancer (PC) is a highly lethal disease and characterized by a strong resistance to current radiotherapy and chemotherapy. As PC has the presence of a microenvironment filled with immunosuppressive mediators and a dense stroma which involved in immune system control, the immune system has been hypothesized to play an important role in PC. However, there was no response in patients who received immune checkpoint inhibitors (ICIs) monotherapy. Though small sample studies revealed that ICIs combined with chemotherapy is effective, a head-to-head comparison of ICIs plu

APA, Harvard, Vancouver, ISO, and other styles

48

Indriastuti, Endah, Endang Retnowati, and Wita Saraswati. "CD4-T LYMPHOCYTE IN CERVICAL CANCER PATIENTS ON PRE- AND POST CHEMOTHERAPY." INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY 26, no. 1 (2019): 30. http://dx.doi.org/10.24293/ijcpml.v26i1.1367.

Full text

Abstract:

Introduction : Cervical cancer is a gynecology cancer with the highest incidence in the Dr.Soetomo Hospital, Surabaya. Neoadjuvant chemotherapy with cisplatin has been used to increase radiosensitivy of cancer cells before radiotherapy done in advanced stage cervical cancer patients. This research aimed to know the differences of CD4-T lymphocyte profile in stage IIIB patient before and after chemotheraphy administration.Methods : This research was done in February-September 2018. Seventeen patients out of 31 stage IIIB cervical cancer patients planned to receive neoadjuvan chemotherapy with c

APA, Harvard, Vancouver, ISO, and other styles

49

Tusan Sidharta, I. Made, I. Ketut Siki Kawiyana, and I. Ketut Suyasa. "Lymphocyte-monocyte ratio as predictive factors for huvos scores in osteosarcoma extremities treated by neoadjuvan chemotherapy (cisplatin and doxorubicin)." International Journal of Research in Medical Sciences 8, no. 11 (2020): 3816. http://dx.doi.org/10.18203/2320-6012.ijrms20204863.

Full text

Abstract:

Background: Chemotherapy is a vital treatment in osteosarcoma but it’s responses are difficult to predict, and there are still no biomarkers that can estimate the prognosis of chemotherapy. Lymphocytes and monocytes are key immune cells which are examined on complete blood count test before chemotherapy and often associated with prognosis of various malignancies. Low lymphocyte-monocyte ratio (LMR) are associated with poor prognostics in some cancers.Methods: This study is cross-sectional retrospective analytics that was conducted at Sanglah Hospital from June to August 2018. The research subj

APA, Harvard, Vancouver, ISO, and other styles

50

Sugo, Maria Evarista, Tiyas Kusumaningrum, and Rista Fauziningtyas. "Faktor Strategi Koping pada Pasien Kanker yang Menjalani Kemoterapi." Pediomaternal Nursing Journal 5, no. 1 (2019): 99. http://dx.doi.org/10.20473/pmnj.v5i1.12459.

Full text

Abstract:

Introduction: Chemotherapy is one of the treatments for cancer that is effective and requires a considerable amount of time so that an adaptive coping strategy is needed from the patient. Patient coping strategies can be influenced by physical, psychological, and social factors. The purpose of this study was to analyze the factors associated with coping strategies for cancer patients undergoing chemotherapy at Prof. W Z Johannes Kupang Hospital.Methods: The design in this study was cross-sectional. The total population were 163 and obtained 100 respondents by consequtive sampling. Independent

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!